13F-HR filed by Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 88 holding rows worth $870,093,347.
- Accession
- 0001420506-25-002082
- Filer
- CIK 1777015
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 88 entries on the cover page, a total value of $870,093,347 stated on the cover page (in dollars after the unit check, H1), rows summing to $870,093,347 with VALUE read as dollars as filed, 13F file number 028-19992. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CVS Health Corporation | 126650100 | COM | 517,807 | $35,718,327 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 105,762 | $33,228,305 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 283,166 | $30,414,860 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 92,338 | $30,110,498 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 168,884 | $29,723,584 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 385,479 | $27,430,686 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 33,296 | $25,955,231 | dollars as filed | |
| QIAGEN NV | N72482206 | COM SHS | 498,107 | $23,939,022 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 240,395 | $21,926,428 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 110,090 | $21,747,179 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 166,010 | $20,865,797 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 50,376 | $19,930,257 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 225,875 | $19,716,629 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 251,741 | $19,688,664 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 197,898 | $18,717,193 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,298,825 | $18,157,574 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 109,500 | $17,256,105 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 175,000 | $16,154,250 | dollars as filed | |
| REVVITY INC | 714046109 | COM | 157,196 | $15,203,997 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 131,675 | $14,598,807 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 488,796 | $13,524,985 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 17,458 | $12,792,873 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 225,150 | $12,376,496 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 827,060 | $12,240,488 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 587,556 | $11,821,627 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 174,276 | $11,476,075 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 386,646 | $11,143,138 | dollars as filed | |
| OUTSET MED INC | 690145206 | COM NEW | 549,052 | $10,547,289 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 871,933 | $9,948,756 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 2,107,483 | $9,841,946 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 119,623 | $9,127,235 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,007,992 | $9,031,608 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 181,643 | $8,871,444 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 162,980 | $8,572,748 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 647,331 | $8,486,509 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 128,478 | $8,383,190 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 896,710 | $8,330,436 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 633,874 | $8,240,362 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 867,813 | $8,127,069 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 175,000 | $7,878,500 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 715,504 | $7,856,234 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 679,063 | $7,676,807 | dollars as filed | |
| DOXIMITY INC CL A | 26622P107 | Stock | 120,834 | $7,411,958 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 40,997 | $7,364,291 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 674,551 | $7,318,878 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 42,108 | $7,267,841 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 648,871 | $7,202,468 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 352,262 | $7,193,190 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 1,900,918 | $7,109,433 | dollars as filed | |
| OPTIMIZERX CORP | 68401U204 | COM NEW | 507,423 | $6,850,211 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 362,008 | $6,812,991 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 463,601 | $6,272,522 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 443,422 | $6,181,303 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 192,705 | $5,993,126 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 220,387 | $5,957,061 | dollars as filed | |
| CERTARA INC COM | 15687V109 | Stock | 500,000 | $5,850,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 200,000 | $5,722,000 | dollars as filed | put |
| WAYSTAR HLDG CORP | 946784105 | COM | 140,000 | $5,721,800 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 147,980 | $5,380,553 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 75,000 | $5,107,500 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 843,998 | $4,962,708 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 599,610 | $4,880,825 | dollars as filed | |
| PERFORMANT HEALTHCARE INC | 71377E105 | COM | 1,214,272 | $4,857,088 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 150,373 | $4,706,675 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 789,099 | $4,639,902 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 650,000 | $4,166,500 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 608,637 | $3,487,490 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 515,992 | $3,431,347 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 61,596 | $3,404,411 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 500,000 | $3,250,000 | dollars as filed | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 913,443 | $3,151,378 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 817,808 | $3,050,424 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,235,305 | $2,804,142 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 116,343 | $2,741,041 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 270,131 | $2,679,700 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 228,271 | $2,600,007 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 8,811 | $2,531,841 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 176,702 | $2,420,817 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 55,404 | $2,406,196 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 1,542,823 | $2,190,809 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 73,412 | $2,111,329 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 605,029 | $1,567,025 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 301,086 | $1,180,257 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 404,194 | $970,066 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 150,000 | $760,500 | dollars as filed | |
| 908 DEVICES INC COM | 65443P102 | Stock | 100,000 | $713,000 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 355,822 | $676,062 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 154,832 | $255,473 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-002082 | this filing | 2025-08-14 | acceptance time not in the bulk data set |